Hewlett-Packard (HP) is under legal scrutiny as a group of consumers filed a proposed federal class action on Friday in a Chicago court, accusing the technology giant of antitrust violations and deceptive practices related to its printers’ ink cartridges.
Eleven consumers hailing from various states, including Illinois, New York, and Missouri, allege that HP engaged in anticompetitive behavior by designing its printers to reject replacement ink cartridges from other manufacturers.
According to Reuters, this compelled consumers to pay artificially inflated prices for HP-branded cartridges, creating an environment conducive to monopolizing the replacement ink market.
Related: HP Wins Quanta’s Factories and Patents In Court
The lawsuit contends that HP failed to inform customers that automatic software updates could disable certain printers unless exclusively using HP-branded ink. This alleged lack of transparency resulted in non-functional printers, coercing consumers into purchasing HP-branded ink cartridges that they would not have otherwise chosen.
The legal action builds upon previous or pending cases against HP, accusing the company of deceptive practices concerning its ink cartridges. In 2019, HP reached a settlement in a California case, agreeing to pay $1.5 million to resolve consumer claims. However, the settlement did not require the company to admit any wrongdoing.
Source: Reuters
Featured News
Justice Department Moves to End NCAA Transfer Rule
May 30, 2024 by
CPI
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI